Meichen Li

546 total citations
37 papers, 291 citations indexed

About

Meichen Li is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Complementary and alternative medicine. According to data from OpenAlex, Meichen Li has authored 37 papers receiving a total of 291 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Pulmonary and Respiratory Medicine, 14 papers in Oncology and 7 papers in Complementary and alternative medicine. Recurrent topics in Meichen Li's work include Lung Cancer Research Studies (13 papers), Lung Cancer Treatments and Mutations (11 papers) and Brain Metastases and Treatment (5 papers). Meichen Li is often cited by papers focused on Lung Cancer Research Studies (13 papers), Lung Cancer Treatments and Mutations (11 papers) and Brain Metastases and Treatment (5 papers). Meichen Li collaborates with scholars based in China and Canada. Meichen Li's co-authors include Likun Chen, Lixia Qiu, Xue Hou, Xuchun Wang, Zeping Ren, Jihong Deng, Quansheng Chen, Hao Ren, Xujie Zhang and Hui Jiang and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Scientific Reports.

In The Last Decade

Meichen Li

30 papers receiving 289 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Meichen Li China	11	90	74	34	32	32	37	291
Tetsuo Ishikawa Japan	7	39 0.4×	36 0.5×	26 0.8×	10 0.3×	17 0.5×	22	284
Pankaj Mathur United States	10	41 0.5×	46 0.6×	106 3.1×	37 1.2×	3 0.1×	31	527
Inese Poļaka Latvia	13	137 1.5×	68 0.9×	80 2.4×	9 0.3×	5 0.2×	65	517
Ji Shao China	10	11 0.1×	25 0.3×	30 0.9×	9 0.3×	32 1.0×	36	334
Florentino Luciano Caetano dos Santos Poland	10	34 0.4×	45 0.6×	43 1.3×	4 0.1×	12 0.4×	35	297
Weilun Wang China	10	47 0.5×	12 0.2×	47 1.4×	50 1.6×	5 0.2×	38	367
Yanqing Xie China	14	187 2.1×	11 0.1×	70 2.1×	19 0.6×	3 0.1×	61	504
Huiyi Li China	10	56 0.6×	28 0.4×	104 3.1×	8 0.3×	3 0.1×	28	349
Erdal Coşgun Türkiye	12	22 0.2×	25 0.3×	49 1.4×	11 0.3×	3 0.1×	34	378
Seungju Lee South Korea	7	86 1.0×	55 0.7×	148 4.4×	8 0.3×	2 0.1×	22	416

Countries citing papers authored by Meichen Li

Since Specialization

Citations

This map shows the geographic impact of Meichen Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meichen Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meichen Li more than expected).

Fields of papers citing papers by Meichen Li

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Meichen Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meichen Li. The network helps show where Meichen Li may publish in the future.

Co-authorship network of co-authors of Meichen Li

This figure shows the co-authorship network connecting the top 25 collaborators of Meichen Li. A scholar is included among the top collaborators of Meichen Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Meichen Li. Meichen Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chen, Jing, et al.. (2025). Efficacy and safety with aumolertinib plus anlotinib for untreated EGFR-mutant NSCLC with brain metastases. npj Precision Oncology. 10(1). 2–2.

Li, Meichen, Na Liu, Hong-Li Zeng, et al.. (2025). Health-related quality of life in populations with diabetes, prediabetes, and normal glycemic levels in Guangzhou, China: a cross-sectional study. Frontiers in Endocrinology. 16. 1518204–1518204.

Chen, Jing, et al.. (2024). Prognostic Nutritional Index Predicts Efficacy and Immune-Related Adverse Events of First-Line Chemoimmunotherapy in Patients with Extensive-Stage Small-Cell Lung Cancer. Journal of Inflammation Research. Volume 17. 1777–1788. 2 indexed citations

Liu, Xinyue, et al.. (2024). A Comparative Full-Length Transcriptome Analysis Using Oxford Nanopore Technologies (ONT) in Four Tissues of Bovine Origin. Animals. 14(11). 1646–1646. 1 indexed citations

Li, Zhanquan, et al.. (2024). Continuing immune checkpoint inhibitors after progression: Real-world patterns of care and outcomes in second-line treatment for extensive-stage small-cell lung cancer. Lung Cancer. 199. 108021–108021. 1 indexed citations

Chen, Jing, et al.. (2024). Adding immune checkpoint inhibitors to chemotherapy confers modest survival benefit in patients with small cell lung cancer and brain metastases: a retrospective analysis. Translational Lung Cancer Research. 13(10). 2479–2490.

Liu, Xin, Meichen Li, Xiaoyan Xie, et al.. (2023). Efficacy of manual acupuncture vs. placebo acupuncture for generalized anxiety disorder (GAD) in perimenopausal women: a randomized, single-blinded controlled trial. Frontiers in Psychiatry. 14. 1240489–1240489. 2 indexed citations

Hou, Xue, Meichen Li, Guowu Wu, et al.. (2023). Gefitinib Plus Chemotherapy vs Gefitinib Alone in Untreated EGFR-Mutant Non–Small Cell Lung Cancer in Patients With Brain Metastases. JAMA Network Open. 6(2). e2255050–e2255050. 23 indexed citations

Wang, Na, Lie Zheng, Meichen Li, et al.. (2023). Clinical efficacy and safety of individualized pembrolizumab administration based on pharmacokinetic in advanced non-small cell lung cancer: A prospective exploratory clinical trial. Lung Cancer. 178. 183–190. 8 indexed citations

10.

Yu, Hui, et al.. (2023). Superior Effectiveness of PD‐1 Inhibitor Plus Chemotherapy versus Bevacizumab Plus Chemotherapy as First‐Line Treatment for Non‐Small Cell Lung Cancer with Brain Metastases. Advanced Therapeutics. 7(3).

11.

Chen, Liang, et al.. (2023). Three-peak evolution characteristics of supporting stress on a super-long working face in a thick coal seam. Frontiers in Energy Research. 11. 1 indexed citations

12.

Ren, Hao, et al.. (2022). Exploring influencing factors of chronic obstructive pulmonary disease based on elastic net and Bayesian network. Scientific Reports. 12(1). 7563–7563. 14 indexed citations

13.

Li, Meichen, et al.. (2022). ALK fusion variant 3a/b, concomitant mutations, and high PD-L1 expression were associated with unfavorable clinical response to second-generation ALK TKIs in patients with advanced ALK-rearranged non-small cell lung cancer (GASTO 1061). Lung Cancer. 165. 54–62. 11 indexed citations

14.

Li, Meichen, et al.. (2022). The efficacy and safety of Jin's three-needle therapy vs. placebo acupuncture on anxiety symptoms in patients with post-stroke anxiety: A study protocol for a randomized controlled trial. Frontiers in Psychiatry. 13. 941566–941566. 4 indexed citations

15.

Wang, Xuchun, Zeping Ren, Hao Ren, et al.. (2021). Exploratory study on classification of diabetes mellitus through a combined Random Forest Classifier. BMC Medical Informatics and Decision Making. 21(1). 105–105. 43 indexed citations

16.

Wang, Xuchun, Jinhua Pan, Zeping Ren, et al.. (2021). Application of a novel hybrid algorithm of Bayesian network in the study of hyperlipidemia related factors: a cross-sectional study. BMC Public Health. 21(1). 1375–1375. 16 indexed citations

17.

Li, Wenhan, Xuchun Wang, Hao Ren, et al.. (2021). Research on the predictive effect of a combined model of ARIMA and neural networks on human brucellosis in Shanxi Province, China: a time series predictive analysis. BMC Infectious Diseases. 21(1). 280–280. 34 indexed citations

18.

Liu, Xin, Xiaoyan Xie, Yingjia Li, et al.. (2021). Efficacy of manual acupuncture versus placebo acupuncture for generalized anxiety disorder (GAD) in perimenopause women: study protocol for a randomized controlled trial. Trials. 22(1). 833–833. 2 indexed citations

19.

Li, Meichen, Xue Hou, Chengzhi Zhou, et al.. (2020). Prevalence and Clinical Impact of Concomitant Mutations in Anaplastic Lymphoma Kinase Rearrangement Advanced Non-small-Cell Lung Cancer (Guangdong Association of Thoracic Oncology Study 1055). Frontiers in Oncology. 10. 1216–1216. 14 indexed citations

20.

Hou, Xue, Delan Li, Ke Sai, et al.. (2020). Management of Non–Small-Cell Lung Cancer Patients Initially Diagnosed With 1 to 3 Synchronous Brain-Only Metastases: A Retrospective Study. Clinical Lung Cancer. 22(1). e25–e34. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact